Literature DB >> 2953803

Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell.

T Kupper, M Horowitz, F Lee, R Robb, P M Flood.   

Abstract

Interleukin 4 (IL 4), formerly known as B cell stimulatory factor 1 (BSF-1), has recently been described as a growth factor for T cells. The role of IL 4 in the putatively IL 2-independent growth of certain cloned T helper cells is unclear. D10.G4.1 (D10) is a conalbumin-specific helper T cell that has been employed extensively in the analysis of T cell activation and as an assay for the detection of IL 1. Previously, it was thought that IL 1 induced the expression of IL 2 receptors on D10 cells, thereby permitting D10 to proliferate in response to endogenously produced IL 2. However, we cannot detect IL 2 mRNA or protein in D10 cells or their supernatants as determined by the following criteria: monoclonal antibodies that neutralize the in vitro activity of murine IL 2 do not block the IL 1-dependent proliferation of D10 cells; no competitive binding for high-affinity IL 2 receptors with 125I-labeled IL 2 can be detected with medium conditioned by activated D10 cells; and Northern blot analysis and S1 nuclease protection assays, performed with cDNA probes for IL 2, do not detect mRNA for IL 2 under a variety of different activation conditions that foster autocrine growth of D10 cells. In contrast, activated D10 cells produce both IL 4 mRNA and protein as judged by similar criteria. Purified IL 4 has significant TCGF activity as measured by proliferation of HT-2 cells. This activity can be blocked completely by a monoclonal antibody to IL 4 (11B11). The proliferation of D10 cells in the presence of 3D3 (a clonotype-specific monoclonal anti-T cell receptor antibody) and IL 1 can be blocked completely by 11B11 antibody. Highly purified IL 4 alone cannot induce the proliferation of resting D10 cells; however, equivalent amounts of IL 4 in the presence of recombinant IL 1 induce significant D10 proliferation. Therefore, IL 1 appears to render D10 cells responsive to their autocrine growth signal. These data indicate that IL 4 serves as the autocrine T cell growth factor for D10 cells, and that exogenous IL 1 is required for the transduction of this growth signal. This may represent a more broadly applicable mechanism for the growth of certain subsets of T helper cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953803

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Temporal protein expression pattern in intracellular signalling cascade during T-cell activation: a computational study.

Authors:  Piyali Ganguli; Saikat Chowdhury; Rupa Bhowmick; Ram Rup Sarkar
Journal:  J Biosci       Date:  2015-10       Impact factor: 1.826

2.  Generation of a T-cell hybridoma producing a contrasuppressor factor for contact sensitivity.

Authors:  A M Friedman; W Ptak; E Brewer; D R Green; P A Reuter; P M Flood
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

3.  Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells.

Authors:  E Muñoz; A M Zubiaga; J Muñoz; B T Huber
Journal:  Cell Regul       Date:  1990-04

4.  IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant Tumors.

Authors:  Tian Tian; Serena Lofftus; Youdong Pan; Claire A Stingley; Sandra L King; Jingxia Zhao; Timothy Y Pan; Rebecca Lock; Jacob W Marglous; Kevin Liu; Hans R Widlund; Robert C Fuhlbrigge; Karen Cichowski; Thomas S Kupper
Journal:  Cancer Immunol Res       Date:  2020-03-11       Impact factor: 11.151

5.  Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the alpha 5 beta 1 integrin.

Authors:  R Pacifici; C Basilico; J Roman; M M Zutter; S A Santoro; R McCracken
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

6.  Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.

Authors:  S Hashimoto; C C McCombs; J P Michalski
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain.

Authors:  T Häupl; G R Burmester; G Hahn; U Feige; C Rordorf-Adam; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

8.  Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

Authors:  J W Mier; G Vachino; J W van der Meer; R P Numerof; S Adams; J G Cannon; H A Bernheim; M B Atkins; D R Parkinson; C A Dinarello
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

9.  Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.

Authors:  R Pacifici; A Carano; S A Santoro; L Rifas; J J Jeffrey; J D Malone; R McCracken; L V Avioli
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

10.  Glycosylation variants of murine interleukin-4: evidence for different functional properties.

Authors:  G Thor; A A Brian
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.